International – Generic Drugmakers Oppose 10 Years Exclusivity for Biologics in US-Mexico Deal

As part of a preliminary trade deal between the US and Mexico, to update the 24-year-old North American Free Trade Agreement (NAFTA), both sides agreed to 10 years of data protection for biologics and expanded scope of products eligible for protection.

But generic drugmakers came out against that deal on Tuesday, as it would be longer than what both Mexico and Canada currently have – Mexico currently enjoys a period of five years of data exclusivity for biologics while Canada uses 10 years…